Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates
暂无分享,去创建一个
François Debaene | S. Cianférani | A. Beck | A. Dorsselaer | Olivier Colas | Elsa Wagner-Rousset | Guillaume Terral | Marie-Claire Janin-Bussat | Julien Marcoux
[1] P. Marathe,et al. Pharmacokinetic characterization of BMS‐936561, an anti‐CD70 antibody‐drug conjugate, in preclinical animal species and prediction of its pharmacokinetics in humans , 2016, Biopharmaceutics & drug disposition.
[2] R. Verma,et al. Immunotoxin therapy for hematologic malignancies: where are we heading? , 2016, Drug discovery today.
[3] F. Cardoso,et al. The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review , 2015, Breast Cancer Research.
[4] S. Radford,et al. Mass spectrometric methods to analyze the structural organization of macromolecular complexes. , 2015, Methods.
[5] J. Otlewski,et al. Current methods for the synthesis of homogeneous antibody-drug conjugates. , 2015, Biotechnology advances.
[6] Yuansheng Zhao,et al. Mass Spectrometry Imaging: Applications in Drug Distribution Studies. , 2015, Current drug metabolism.
[7] M. Squires,et al. A rapid approach for characterization of thiol-conjugated antibody-drug conjugates and calculation of drug-antibody ratio by liquid chromatography mass spectrometry. , 2015, Analytical biochemistry.
[8] Mallory R Gordon,et al. Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists. , 2015, Bioconjugate chemistry.
[9] S. Cianférani,et al. MAPN: First-in-Class Reagent for Kinetically Resolved Thiol-to-Thiol Conjugation. , 2015, Bioconjugate chemistry.
[10] G. S. Hamilton. Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids. , 2015, Biologicals : journal of the International Association of Biological Standardization.
[11] Qun Zhou,et al. Advances in the Development of Site-Specific Antibody-Drug Conjugation. , 2015, Anti-cancer agents in medicinal chemistry.
[12] Weibin Chen,et al. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography , 2015, mAbs.
[13] Ž. Reiner. PCSK9 inhibitors – past, present and future , 2015, Expert opinion on drug metabolism & toxicology.
[14] E. Fischer,et al. Antibody Conjugates: From Heterogeneous Populations to Defined Reagents , 2015 .
[15] S. Cianférani,et al. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine‐linked antibody drug conjugate , 2015, Protein science : a publication of the Protein Society.
[16] A. Heck,et al. Lysine conjugation properties in human IgGs studied by integrating high‐resolution native mass spectrometry and bottom‐up proteomics , 2015, Proteomics.
[17] Frederik Lermyte,et al. Electron transfer dissociation provides higher‐order structural information of native and partially unfolded protein complexes , 2015, Proteomics.
[18] S. Girish,et al. Bioanalytical approaches for characterizing catabolism of antibody-drug conjugates. , 2015, Bioanalysis.
[19] D. Guillarme,et al. Direct identification of rituximab main isoforms and subunit analysis by online selective comprehensive two-dimensional liquid chromatography-mass spectrometry. , 2015, Analytical chemistry.
[20] M. Carrasco-Triguero. Insights on the immunogenicity of antibody-drug conjugates. , 2015, Bioanalysis.
[21] S. Deshpande,et al. Challenges in antibody-drug conjugate discovery: a bioconjugation and analytical perspective. , 2015, Bioanalysis.
[22] Sharad Sharma,et al. Integration of bioanalytical measurements using PK-PD modeling and simulation: implications for antibody-drug conjugate development. , 2015, Bioanalysis.
[23] B. Gorovits,et al. Antibody-drug conjugates nonclinical support: from early to late nonclinical bioanalysis using ligand-binding assays. , 2015, Bioanalysis.
[24] B. Gorovits. Bioanalysis of antibody-drug conjugates. , 2015, Bioanalysis.
[25] Xiaogang Han,et al. In vivo biotransformations of antibody-drug conjugates. , 2015, Bioanalysis.
[26] Xiuling Li,et al. Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues. , 2015, Bioconjugate chemistry.
[27] John R Engen,et al. Analytical Aspects of Hydrogen Exchange Mass Spectrometry. , 2015, Annual review of analytical chemistry.
[28] A. Plückthun,et al. Antibody-Drug Conjugates for Tumor Targeting-Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins. , 2015, Bioconjugate chemistry.
[29] M. Dorywalska,et al. Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading , 2015, Nature Biotechnology.
[30] Ekaterina G. Deyanova,et al. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates , 2015, Journal of The American Society for Mass Spectrometry.
[31] P. Qasba. Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases. , 2015, Bioconjugate chemistry.
[32] F. V. van Delft,et al. Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody-Drug Conjugates. , 2015, Bioconjugate chemistry.
[33] John F. Valliere-Douglass,et al. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry. , 2015, Molecular pharmaceutics.
[34] K. Roux,et al. Epitope mapping of 7S cashew antigen in complex with antibody by solution-phase H/D exchange monitored by FT-ICR mass spectrometry. , 2015, Journal of mass spectrometry : JMS.
[35] P. Parren,et al. Tandem Native Mass-Spectrometry on Antibody-Drug Conjugates and Submillion Da Antibody-Antigen Protein Assemblies on an Orbitrap EMR Equipped with a High-Mass Quadrupole Mass Selector. , 2015, Analytical chemistry.
[36] Darryl B. Hardie,et al. Fast Comparative Structural Characterization of Intact Therapeutic Antibodies Using Hydrogen-Deuterium Exchange and Electron Transfer Dissociation. , 2015, Analytical chemistry.
[37] Tilman Schlothauer,et al. Functional assessment of antibody oxidation by native mass spectrometry , 2015, mAbs.
[38] Yannis-Nicolas François,et al. Glycoform Separation and Characterization of Cetuximab Variants by Middle-up Off-Line Capillary Zone Electrophoresis-UV/Electrospray Ionization-MS. , 2015, Analytical chemistry.
[39] S. Singh,et al. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability , 2015, Pharmaceutical Research.
[40] L. Poppe,et al. On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR Methods. , 2015, Analytical chemistry.
[41] Colin D. Medley,et al. A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates. , 2015, Journal of chromatography. A.
[42] M. Wolfe,et al. Photoinduced aggregation of a model antibody-drug conjugate. , 2015, Molecular pharmaceutics.
[43] Lauren F. Stevenson,et al. Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment , 2015, The AAPS Journal.
[44] M. Jaquinod,et al. Absolute and multiplex quantification of antibodies in serum using PSAQ™ standards and LC-MS/MS. , 2015, Bioanalysis.
[45] S. Bishop,et al. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody , 2015, mAbs.
[46] J. Leighton,et al. An FDA oncology analysis of antibody-drug conjugates. , 2015, Regulatory toxicology and pharmacology : RTP.
[47] G. Ratnaswamy,et al. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates. , 2015, Journal of pharmaceutical sciences.
[48] S. Cianférani,et al. Characterization of the N-terminal heterogeneities of monoclonal antibodies using in-gel charge derivatization of α-amines and LC-MS/MS. , 2015, Analytical chemistry.
[49] Rajeeva Singh,et al. Sensitive ELISA Method for the Measurement of Catabolites of Antibody-Drug Conjugates (ADCs) in Target Cancer Cells. , 2015, Molecular pharmaceutics.
[50] M. Dorywalska,et al. Effect of attachment site on stability of cleavable antibody drug conjugates. , 2015, Bioconjugate chemistry.
[51] A. Beck,et al. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[52] P. Dalby,et al. The Solution Structures of Two Human IgG1 Antibodies Show Conformational Stability and Accommodate Their C1q and FcγR Ligands* , 2015, The Journal of Biological Chemistry.
[53] Alain Van Dorsselaer,et al. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. , 2015, Journal of mass spectrometry : JMS.
[54] John F. Valliere-Douglass,et al. Solid-state mAbs and ADCs subjected to heat-stress stability conditions can be covalently modified with buffer and excipient molecules. , 2015, Journal of pharmaceutical sciences.
[55] D. Volkin,et al. Hydrogen-deuterium exchange mass spectrometry as an emerging analytical tool for stabilization and formulation development of therapeutic monoclonal antibodies. , 2015, Journal of pharmaceutical sciences.
[56] Alain Wagner,et al. CBTF: new amine-to-thiol coupling reagent for preparation of antibody conjugates with increased plasma stability. , 2015, Bioconjugate chemistry.
[57] Louise Robinson,et al. Long-term stabilization of maleimide-thiol conjugates. , 2015, Bioconjugate chemistry.
[58] D. Guillarme,et al. Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach. , 2015, Journal of pharmaceutical and biomedical analysis.
[59] Janice M Reichert,et al. Antibodies to watch in 2015 , 2015, mAbs.
[60] C. Bertozzi,et al. Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development , 2014, Bioconjugate chemistry.
[61] S. Ramanujan,et al. Semi-mechanistic Multiple-Analyte Pharmacokinetic Model for an Antibody-Drug-Conjugate in Cynomolgus Monkeys , 2014, Pharmaceutical Research.
[62] Davy Guillarme,et al. Theory and practice of size exclusion chromatography for the analysis of protein aggregates. , 2014, Journal of pharmaceutical and biomedical analysis.
[63] M. Hilger,et al. Investigating the Interaction between the Neonatal Fc Receptor and Monoclonal Antibody Variants by Hydrogen/Deuterium Exchange Mass Spectrometry* , 2014, Molecular & Cellular Proteomics.
[64] Yannis-Nicolas François,et al. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry , 2014, mAbs.
[65] O. Chinot,et al. Monitoring therapeutic monoclonal antibodies in brain tumor , 2014, mAbs.
[66] Alain Van Dorsselaer,et al. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment. , 2014, Analytical chemistry.
[67] F. Loganzo,et al. Mild method for succinimide hydrolysis on ADCs: impact on ADC potency, stability, exposure, and efficacy. , 2014, Bioconjugate chemistry.
[68] C. Bodet-Milin,et al. Radioimmunoconjugates for the treatment of cancer. , 2014, Seminars in oncology.
[69] Alain Beck,et al. Analysis of monoclonal antibody by a novel CE‐UV/MALDI‐MS interface , 2014, Electrophoresis.
[70] A. Beck,et al. Advantages of extended bottom-up proteomics using Sap9 for analysis of monoclonal antibodies. , 2014, Analytical chemistry.
[71] P. Senter,et al. Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates , 2014, Nature Biotechnology.
[72] Yannis-Nicolas François,et al. Full antibody primary structure and microvariant characterization in a single injection using transient isotachophoresis and sheathless capillary electrophoresis-tandem mass spectrometry. , 2014, Analytical chemistry.
[73] Vaughn V. Smider,et al. Unnatural amino acids in novel antibody conjugates. , 2014, Future medicinal chemistry.
[74] S. Akashi,et al. Characterization of Stress-Exposed Granulocyte Colony Stimulating Factor Using ELISA and Hydrogen/Deuterium Exchange Mass Spectrometry , 2014, Journal of The American Society for Mass Spectrometry.
[75] Massimiliano Porrini,et al. Dynamics of intact immunoglobulin G explored by drift-tube ion-mobility mass spectrometry and molecular modeling. , 2014, Angewandte Chemie.
[76] R. Borzilleri,et al. Antibody-drug conjugates: current status and future directions. , 2014, Drug discovery today.
[77] Yan Chen,et al. Statistical modeling of the drug load distribution on trastuzumab emtansine (Kadcyla), a lysine-linked antibody drug conjugate. , 2014, Bioconjugate chemistry.
[78] M. Quaglia,et al. Quantification of human growth hormone in serum with a labeled protein as an internal standard: essential considerations. , 2014, Analytical chemistry.
[79] R. Chari,et al. Antibody—Drug Conjugates: An Emerging Concept in Cancer Therapy , 2014 .
[80] A. Deslandes. Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies , 2014, mAbs.
[81] R. Chari,et al. Antibody-drug conjugates: an emerging concept in cancer therapy. , 2014, Angewandte Chemie.
[82] Sébastien Brier,et al. Two cross‐reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[83] Mohammed Shameem,et al. Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications , 2014, mAbs.
[84] A. Heck,et al. Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry , 2014, Nature Protocols.
[85] Carolyn R. Bertozzi,et al. Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags , 2014, Bioconjugate chemistry.
[86] John F. Valliere-Douglass,et al. Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry. , 2014, Analytical chemistry.
[87] Aston Liu,et al. Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling. , 2014, Analytical chemistry.
[88] Kelly A. Schwarz,et al. Auristatin antibody drug conjugate physical instability and the role of drug payload. , 2014, Bioconjugate chemistry.
[89] A. Beck,et al. Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry. , 2014, Analytical chemistry.
[90] John F. Valliere-Douglass,et al. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry. , 2014, Analytical chemistry.
[91] E. Fischer,et al. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates. , 2014, Bioconjugate chemistry.
[92] Sandeep Kumar,et al. Assessment of Physical Stability of an Antibody Drug Conjugate by Higher Order Structure Analysis: Impact of Thiol- Maleimide Chemistry , 2014, Pharmaceutical Research.
[93] Weidong Cui,et al. Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies , 2014, FEBS letters.
[94] Carol V. Robinson,et al. Dynamic protein ligand interactions – insights from MS , 2014, The FEBS journal.
[95] T. Wurch,et al. 9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland , 2014, mAbs.
[96] M. Dorywalska,et al. Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates. , 2014, Bioconjugate chemistry.
[97] Natalie J. Thompson,et al. Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry , 2014, mAbs.
[98] P. Strop,et al. World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA , 2013, mAbs.
[99] D. Blanset,et al. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology. , 2013, Regulatory toxicology and pharmacology : RTP.
[100] S. Meeks,et al. Epitope mapping of inhibitory antibodies targeting the C2 domain of coagulation factor VIII by hydrogen–deuterium exchange mass spectrometry , 2013, Journal of thrombosis and haemostasis : JTH.
[101] L. Makowski,et al. Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements. , 2013, Journal of pharmaceutical sciences.
[102] Paul Polakis,et al. Site-specific antibody drug conjugates for cancer therapy , 2013, mAbs.
[103] A. Beck. Review of Antibody-Drug Conjugates, Methods in Molecular Biology series , 2013, mAbs.
[104] Alain Beck,et al. Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion , 2013, mAbs.
[105] François Debaene,et al. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. , 2013, Analytical chemistry.
[106] Heather Flores,et al. Investigation into temperature-induced aggregation of an antibody drug conjugate. , 2013, Bioconjugate chemistry.
[107] P. Burke,et al. Metabolic engineering of monoclonal antibody carbohydrates for antibody-drug conjugation. , 2013, Bioconjugate chemistry.
[108] P. Parren,et al. In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap , 2013, mAbs.
[109] I. Bernstein,et al. SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. , 2013, Blood.
[110] François Debaene,et al. Analytical characterization of biosimilar antibodies and Fc-fusion proteins , 2013 .
[111] P. Burke,et al. A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology. , 2013, Bioconjugate chemistry.
[112] D. Suckau,et al. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques , 2013, mAbs.
[113] J. Laurence,et al. Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates. , 2013, Bioconjugate chemistry.
[114] S. Alley,et al. Analytical and bioanalytical technologies for characterizing antibody-drug conjugates. , 2013, Current opinion in chemical biology.
[115] A. Walch,et al. Current frontiers in clinical research application of MALDI imaging mass spectrometry , 2013, Expert review of proteomics.
[116] J. R. Junutula,et al. Characterization of the drug-to-antibody ratio distribution for antibody-drug conjugates in plasma/serum. , 2013, Bioanalysis.
[117] Surinder Kaur,et al. Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine. , 2013, Bioanalysis.
[118] Surinder Kaur,et al. Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper. , 2013, Bioanalysis.
[119] W. Xu,et al. Method to convert N-terminal glutamine to pyroglutamate for characterization of recombinant monoclonal antibodies. , 2013, Analytical biochemistry.
[120] Alain Beck,et al. Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry , 2013, mAbs.
[121] A. Marshall,et al. Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation-Fourier transform ion cyclotron resonance-mass spectrometry. , 2013, Analytical chemistry.
[122] M. Gross,et al. Complementary MS Methods Assist Conformational Characterization of Antibodies with Altered S–S Bonding Networks , 2013, Journal of The American Society for Mass Spectrometry.
[123] Lloyd M. Smith,et al. Proteoform: a single term describing protein complexity , 2013, Nature Methods.
[124] Sheng Yin,et al. Development of a native nanoelectrospray mass spectrometry method for determination of the drug-to-antibody ratio of antibody-drug conjugates. , 2013, Analytical chemistry.
[125] Alain Van Dorsselaer,et al. Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.
[126] Thomas H Pillow,et al. Antibody‐Drug Conjugates for the Treatment of Cancer , 2013, Chemical biology & drug design.
[127] Natalie J. Thompson,et al. Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry. , 2012, Angewandte Chemie.
[128] M. Bardor,et al. Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins , 2012, Biotechnology journal.
[129] A. Beck,et al. Fourth World Antibody-Drug Conjugate Summit , 2012, mAbs.
[130] Peter G Schultz,et al. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids , 2012, Proceedings of the National Academy of Sciences.
[131] Neil L. Kelleher,et al. Analysis of Intact Monoclonal Antibody IgG1 by Electron Transfer Dissociation Orbitrap FTMS* , 2012, Molecular & Cellular Proteomics.
[132] W. J. Galush,et al. Profiling antibody drug conjugate positional isomers: a system-of-equations approach. , 2012, Analytical chemistry.
[133] P. Senter,et al. The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma , 2012, Nature Biotechnology.
[134] P. Barran,et al. Mass spectrometry based tools to investigate protein-ligand interactions for drug discovery. , 2012, Chemical Society reviews.
[135] Alain Van Dorsselaer,et al. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. , 2012, Analytical chemistry.
[136] M. Joubert,et al. Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses , 2012, The Journal of Biological Chemistry.
[137] W. Atkins,et al. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates , 2012, mAbs.
[138] John F. Valliere-Douglass,et al. Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues. , 2012, Analytical chemistry.
[139] S. Tuske,et al. Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking , 2012, Journal of molecular recognition : JMR.
[140] Lorna J. Smith,et al. Charge-state dependent compaction and dissociation of protein complexes: insights from ion mobility and molecular dynamics. , 2012, Journal of the American Chemical Society.
[141] M. Sliwkowski,et al. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates , 2012, Nature Biotechnology.
[142] F. Wurm,et al. Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry. , 2011, Analytical chemistry.
[143] R. Lutz,et al. SAR3419: An Anti-CD19-Maytansinoid Immunoconjugate for the Treatment of B-Cell Malignancies , 2011, Clinical Cancer Research.
[144] Richard D. LeDuc,et al. Mapping Intact Protein Isoforms in Discovery Mode Using Top Down Proteomics , 2011, Nature.
[145] N. Bihoreau,et al. Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry. , 2011, Analytical biochemistry.
[146] A. Beck,et al. World Antibody Drug Conjugate Summit Europe , 2011, mAbs.
[147] Hongcheng Liu,et al. Quantitation of a recombinant monoclonal antibody in monkey serum by liquid chromatography-mass spectrometry. , 2011, Analytical biochemistry.
[148] Boyan Zhang,et al. Identification of amino acid residues responsible for the release of free drug from an antibody-drug conjugate utilizing lysine-succinimidyl ester chemistry. , 2011, Journal of pharmaceutical sciences.
[149] S. Berkowitz,et al. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. , 2011, Journal of pharmaceutical sciences.
[150] Surinder Kaur,et al. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry. , 2011, Analytical biochemistry.
[151] Marisa K Joubert,et al. Classification and Characterization of Therapeutic Antibody Aggregates , 2011, The Journal of Biological Chemistry.
[152] E. Ezan,et al. MS-based approaches for studying the pharmacokinetics of protein drugs. , 2011, Bioanalysis.
[153] Aditya A Wakankar,et al. Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.
[154] Satish K. Singh,et al. A New Approach to Explore the Impact of Freeze-Thaw Cycling on Protein Structure: Hydrogen/Deuterium Exchange Mass Spectrometry (HX-MS) , 2011, Pharmaceutical Research.
[155] M. Kinoshita,et al. Charge heterogeneity of a therapeutic monoclonal antibody conjugated with a cytotoxic antitumor antibiotic, calicheamicin. , 2010, Journal of chromatography. A.
[156] Christian Bailly,et al. The next generation of antibody-drug conjugates comes of age. , 2010, Discovery medicine.
[157] C. Fegan,et al. SG2285, a novel C2-aryl-substituted pyrrolobenzodiazepine dimer prodrug that cross-links DNA and exerts highly potent antitumor activity. , 2010, Cancer research.
[158] Aditya A Wakankar,et al. Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes. , 2010, Bioconjugate chemistry.
[159] Vasco Filipe,et al. Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography , 2010, Pharmaceutical Research.
[160] P. Schnier,et al. Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry. , 2010, Analytical chemistry.
[161] Christian Bailly,et al. Strategies and challenges for the next generation of therapeutic antibodies , 2010, Nature Reviews Immunology.
[162] W. Burkitt,et al. Conformational changes in oxidatively stressed monoclonal antibodies studied by hydrogen exchange mass spectrometry , 2010, Protein science : a publication of the Protein Society.
[163] S. Berkowitz,et al. Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry , 2010, Journal of the American Society for Mass Spectrometry.
[164] A. Safavy,et al. Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy. , 2010, Journal of medicinal chemistry.
[165] Damian Houde,et al. Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding* , 2010, Molecular & Cellular Proteomics.
[166] E. Ezan,et al. Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies. , 2009, Bioanalysis.
[167] P. Parren,et al. Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo , 2009, Nature Biotechnology.
[168] Arnaud H. Muller,et al. Characterization of human and bovine phosphatidylethanolamine-binding protein (PEBP/RKIP) interactions with morphine and morphine-glucuronides determined by noncovalent mass spectrometry. , 2009, Medical science monitor : international medical journal of experimental and clinical research.
[169] Mathieu Dubois,et al. Bioanalysis of recombinant proteins and antibodies by mass spectrometry. , 2009, The Analyst.
[170] C. Scarff,et al. Probing hemoglobin structure by means of traveling-wave ion mobility mass spectrometry , 2009, Journal of the American Society for Mass Spectrometry.
[171] P. Bondarenko,et al. Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer , 2009, Journal of the American Society for Mass Spectrometry.
[172] John M Lambert,et al. Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. , 2008, Cancer research.
[173] Paul Polakis,et al. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index , 2008, Nature Biotechnology.
[174] Olivier Heudi,et al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. , 2008, Analytical chemistry.
[175] Colleen E. Price,et al. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[176] Damon L. Meyer,et al. Contribution of linker stability to the activities of anticancer immunoconjugates. , 2008, Bioconjugate chemistry.
[177] Darrell Ricke,et al. Absolute quantification of monoclonal antibodies in biofluids by liquid chromatography-tandem mass spectrometry. , 2008, Analytical chemistry.
[178] Margaret Ricci,et al. The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. , 2007, Journal of pharmaceutical sciences.
[179] B. Yan,et al. Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry. , 2007, Journal of chromatography. A.
[180] Zhongqi Zhang,et al. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry. , 2007, Analytical chemistry.
[181] E. Ezan,et al. Immuno-mass spectrometry assay of EPI-HNE4, a recombinant protein inhibitor of human elastase. , 2007, Rapid communications in mass spectrometry : RCM.
[182] A. Rosenberg,et al. Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.
[183] Gerd R Kleemann,et al. Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC/MS analysis. , 2006, Analytical biochemistry.
[184] Jennifer B. Webster,et al. Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment. , 2006, Protein engineering, design & selection : PEDS.
[185] C. Robinson,et al. Evidence for Macromolecular Protein Rings in the Absence of Bulk Water , 2005, Science.
[186] M. Pasquali,et al. Acidified acetonitrile and methanol extractions for quantitative analysis of acylcarnitines in plasma by stable isotope dilution tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[187] Michael M C Sun,et al. Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides. , 2005, Bioconjugate chemistry.
[188] John M Lambert,et al. Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometry , 2005, Protein science : a publication of the Protein Society.
[189] John M. Lambert,et al. Structural Characterization of a Recombinant Monoclonal Antibody by Electrospray Time-of-Flight Mass Spectrometry , 2005, Pharmaceutical Research.
[190] A. Lazar,et al. Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.
[191] Wei Zhang,et al. A reversed-phase high-performance liquid chromatography method for analysis of monoclonal antibody-maytansinoid immunoconjugates. , 2005, Analytical biochemistry.
[192] F. Hsieh,et al. Mass spectral analyses of labile DOTA-NHS and heterogeneity determination of DOTA or DM1 conjugated anti-PSMA antibody for prostate cancer therapy. , 2005, Journal of pharmaceutical sciences.
[193] Damon L. Meyer,et al. Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate , 2004, Clinical Cancer Research.
[194] Alain Van Dorsselaer,et al. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[195] K. Aldape,et al. A model of molecular interactions on short oligonucleotide microarrays , 2003, Nature Biotechnology.
[196] P. Trail,et al. Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains. , 2002, Journal of medicinal chemistry.
[197] X. H. Chen,et al. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[198] M. Bowers,et al. Gas-Phase Ion Chromatography: Transition Metal State Selection and Carbon Cluster Formation , 1993, Science.
[199] D. Guillarme,et al. Adsorption and recovery issues of recombinant monoclonal antibodies in reversed-phase liquid chromatography. , 2015, Journal of separation science.
[200] Devharsh Trivedi,et al. Overview and Applications , 2015 .
[201] Albert J R Heck,et al. Performing native mass spectrometry analysis on therapeutic antibodies. , 2014, Methods.
[202] D. Neri,et al. Armed antibodies for cancer treatment: a promising tool in a changing era , 2014, Cancer Immunology, Immunotherapy.
[203] A. Beck,et al. Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion. , 2014, mAbs.
[204] Louisette Basa,et al. Drug-to-antibody ratio (DAR) and drug load distribution by LC-ESI-MS. , 2013, Methods in molecular biology.
[205] J. Ouyang,et al. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography. , 2013, Methods in molecular biology.
[206] Yan Chen,et al. Drug-to-antibody ratio (DAR) by UV/Vis spectroscopy. , 2013, Methods in molecular biology.
[207] P. Wingfield,et al. Sizing up large protein complexes by electrospray ionisation-based electrophoretic mobility and native mass spectrometry: morphology selective binding of Fabs to hepatitis B virus capsids , 2013, Analytical and Bioanalytical Chemistry.
[208] Lihua Huang,et al. Epitope mapping of antibodies by mass spectroscopy: a case study. , 2013, Methods in molecular biology.
[209] A. Lazar,et al. Determination of charge heterogeneity and level of unconjugated antibody by imaged cIEF. , 2013, Methods in molecular biology.
[210] A. Beck,et al. Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry. , 2013, Methods in molecular biology.
[211] Laurent Ducry,et al. Antibody-Drug Conjugates , 2013, Methods in Molecular Biology.
[212] E. Ezan,et al. Mass spectrometry protocol for the absolute quantification of a monoclonal antibody in serum with immunopurification. , 2013, Methods in molecular biology.
[213] P. Senter,et al. Conjugation of anticancer drugs through endogenous monoclonal antibody cysteine residues. , 2012, Methods in enzymology.
[214] M. Shirts,et al. Distinct Aggregation Mechanisms of Monoclonal Antibody Under Thermal and Freeze-Thaw Stresses Revealed by Hydrogen Exchange , 2011, Pharmaceutical Research.
[215] Gérard Hopfgartner,et al. Accelerated tryptic digestion for the analysis of biopharmaceutical monoclonal antibodies in plasma by liquid chromatography with tandem mass spectrometric detection. , 2010, Journal of chromatography. A.
[216] P. Bondarenko,et al. Top-down N-terminal sequencing of Immunoglobulin subunits with electrospray ionization time of flight mass spectrometry. , 2009, Analytical biochemistry.
[217] I. Hollander,et al. Selection of reaction additives used in the preparation of monomeric antibody-calicheamicin conjugates. , 2008, Bioconjugate chemistry.
[218] Peter D. Senter,et al. Development of potent monoclonal antibody auristatin conjugates for cancer therapy , 2003 .
[219] H. Shinmoto,et al. [Bispecific antibodies]. , 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[220] Bairong Shen,et al. Translational Biomedical Informatics in the Cloud: Present and Future , 2013, BioMed research international.